CSK

General Information


DRACP ID  DRACP05613

Peptide Name   CSK

Sequence  CSKSSDYQC

Sequence Length  9

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Conjugation to solid lipid nanoparticle

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C39H61N11O17S2

Absent amino acids  AEFGHILMNPRTVW

Common amino acids  S

Mass  116297

Pl  6.06

Basic residues  1

Acidic residues  1

Hydrophobic residues  0

Net charge  0

Boman Index  -2759

Hydrophobicity  -106.67

Aliphatic Index  0

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  1615

Absorbance 280nm  201.88

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24968819

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2488

DRACP is developed by Dr.Zheng's team.